Skip to content
← Back to this collection

PUBLICATIONS · 24836273

Effect of radium-223 dichloride on symptomatic skeletal events in patients with castration-resistant prostate cancer and bone metastases: results from a phase 3, double-blind, randomised trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Lancet Oncol
Publication date
2014 Jun
First author
Sartor O

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2014 Jun;15(7):675-6. doi: 10.1016/S1470-2045(14)70217-7.
    note
    Source null
    related pmid
    24836275
    relationship
    Comment in
  2. citation
    J Urol. 2015 Mar;193(3):847-8. doi: 10.1016/j.juro.2014.12.077.
    note
    Source null
    related pmid
    25765385
    relationship
    Comment in

Authors and identifiers

  1. name
    Sartor O
    type
    Author
  2. name
    Coleman R
    type
    Author
  3. name
    Nilsson S
    type
    Author
  4. name
    Heinrich D
    type
    Author
  5. name
    Helle SI
    type
    Author
  6. name
    O'Sullivan JM
    type
    Author
  7. name
    Fosså SD
    type
    Author
  8. name
    Chodacki A
    type
    Author
  9. name
    Wiechno P
    type
    Author
  10. name
    Logue J
    type
    Author
  11. name
    Widmark A
    type
    Author
  12. name
    Johannessen DC
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Sartor O
    type
    Author
  2. name
    Coleman R
    type
    Author
  3. name
    Nilsson S
    type
    Author
  4. name
    Heinrich D
    type
    Author
  5. name
    Helle SI
    type
    Author
  6. name
    O'Sullivan JM
    type
    Author
  7. name
    Fosså SD
    type
    Author
  8. name
    Chodacki A
    type
    Author
  9. name
    Wiechno P
    type
    Author
  10. name
    Logue J
    type
    Author
  11. name
    Widmark A
    type
    Author
  12. name
    Johannessen DC
    type
    Author
bibliography ids
  1. nci-bib-48ca80aa565a2bb3cd1f2122
book metadata
content sha256
8ebbda1f64f341509d762106a54595c32dd5b67cbb36ffbdf1aabf50bf0bd06b
document type
citation
dois
  1. 10.1016/S1470-2045(14)70183-4
electronic publication date
display
2014 May 13
precision
day
year
2014
evidence scope
bibliographic_metadata_only
id
pubmed:24836273
immutable id
pubmed:24836273@8ebbda1f64f341509d762106a54595c32dd5b67cbb36ffbdf1aabf50bf0bd06b
journal
abbreviation
Lancet Oncol
issn electronic
1474-5488
issn print
1470-2045
issue
7
name
The Lancet. Oncology
nlm unique id
100957246
pages
738-46
volume
15
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2014 Jun;15(7):675-6. doi: 10.1016/S1470-2045(14)70217-7.
    note
    Source null
    related pmid
    24836275
    relationship
    Comment in
  2. citation
    J Urol. 2015 Mar;193(3):847-8. doi: 10.1016/j.juro.2014.12.077.
    note
    Source null
    related pmid
    25765385
    relationship
    Comment in
outcomes validated
false
pmid
24836273
provenance
batch id
063b6c38419f18d4021f
provider
NCBI PubMed ESummary
record sha256
ed96dd3defd8d1323efe9c2cf5d4de717022988b53ae2334c9b7502b4edd037b
response sha256
5abcae41e9384a85f92695ef76b244ffd933f07a58a51082c160af8743d196ad
retrieved at
2026-09-09T23:47:02.607425+00:00
publication date
display
2014 Jun
precision
month
year
2014
publication types
  1. Clinical Trial, Phase III
  2. Journal Article
  3. Randomized Controlled Trial
  4. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/24836273/
title
Effect of radium-223 dichloride on symptomatic skeletal events in patients with castration-resistant prostate cancer and bone metastases: results from a phase 3, double-blind, randomised trial.

Preserved source evidence · Not medical advice